癌症恶病质：一种营养相关还是系统性炎症综合征？
Cancer cachexia: a nutritional or a systemic inflammatory syndrome?
机构信息
Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
Institute of Cancer, University of Edinburgh, Edinburgh, UK.
出版信息
Br J Cancer. 2022 Aug;127(3):379-382. doi: 10.1038/s41416-022-01826-2. Epub 2022 May 6.
Abstract
Cancer cachexia has long been perceived as a nutritional syndrome. However, nutritional interventions have continued to be ineffective. With the recent recognition of the importance of systemic inflammation in the definition of this syndrome and treatment, has the time come to consider whether this syndrome is primarily a manifestation of systemic inflammation with the consequent implications for future treatment?
摘要
癌症恶病质长期以来一直被认为是一种营养综合征。然而，营养干预一直没有效果。随着最近认识到全身炎症在该综合征的定义和治疗中的重要性，是否到了考虑这种综合征是否主要是全身炎症表现的时候了，以及这对未来治疗的影响？
相似文献
1
Cancer cachexia: a nutritional or a systemic inflammatory syndrome?癌症恶病质：一种营养相关还是系统性炎症综合征？
Br J Cancer. 2022 Aug;127(3):379-382. doi: 10.1038/s41416-022-01826-2. Epub 2022 May 6.
2
Cancer cachexia: from molecular mechanisms to patient's care.癌症恶病质：从分子机制到患者护理
Crit Rev Oncog. 2012;17(3):315-21. doi: 10.1615/critrevoncog.v17.i3.90.
3
Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota.骨骼肌在癌症免疫治疗中的作用：聚焦肌肉功能、炎症和微生物组。
Nutrition. 2023 Jan;105:111829. doi: 10.1016/j.nut.2022.111829. Epub 2022 Aug 21.
4
[Cachexia in cancer patients].[癌症患者的恶病质]
Magy Onkol. 2016 Nov 29;60(4):281-287. Epub 2016 May 2.
5
The Evolving Approach to Management of Cancer Cachexia.癌症恶病质管理的不断演进方法
Oncology (Williston Park). 2017 Jan 15;31(1):23-32.
6
Rethinking nutritional support for persons with cancer cachexia.对癌症恶病质患者营养支持的重新思考。
Biol Res Nurs. 2003 Jul;5(1):3-17. doi: 10.1177/1099800403005001001.
7
Cancer cachexia: towards integrated therapeutic interventions.癌症恶病质：走向综合治疗干预
Expert Opin Biol Ther. 2014 Oct;14(10):1379-81. doi: 10.1517/14712598.2014.939068. Epub 2014 Jul 12.
8
Systemic inflammation, nutritional status and survival in patients with cancer.癌症患者的全身炎症、营养状况与生存情况
Curr Opin Clin Nutr Metab Care. 2009 May;12(3):223-6. doi: 10.1097/MCO.0b013e32832a7902.
9
Inflammatory burden and amino acid metabolism in cancer cachexia.癌症恶病质中的炎症负荷与氨基酸代谢
Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):72-7. doi: 10.1097/MCO.0b013e32831cef61.
10
Cancer cachexia: Diagnosis, assessment, and treatment.癌症恶病质：诊断、评估与治疗。
Crit Rev Oncol Hematol. 2018 Jul;127:91-104. doi: 10.1016/j.critrevonc.2018.05.006. Epub 2018 May 31.
引用本文的文献
1
Diaphragm Function in Health and Disease.健康与疾病状态下的膈肌功能
Adv Exp Med Biol. 2025;1478:615-630. doi: 10.1007/978-3-031-88361-3_25.
2
Cancer Cachexia.癌症恶病质
Adv Exp Med Biol. 2025;1478:285-314. doi: 10.1007/978-3-031-88361-3_12.
3
Not All Weight Loss Is Equal: Divergent Patterns and Prognostic Roles in Head and Neck Cancer Versus High-Grade B-Cell Lymphoma.并非所有体重减轻都相同：头颈癌与高级别B细胞淋巴瘤的不同模式及预后作用
Nutrients. 2025 Jul 31;17(15):2530. doi: 10.3390/nu17152530.
4
The Advanced Lung Cancer Inflammation Index and Mortality in Patients with Cardiovascular-Kidney Metabolic Syndrome: Insights from NHANES.心血管-肾脏代谢综合征患者的晚期肺癌炎症指数与死亡率：来自美国国家健康与营养检查调查（NHANES）的见解
BMC Cardiovasc Disord. 2025 Aug 2;25(1):568. doi: 10.1186/s12872-025-05019-6.
5
Malnutrition risk as a predictor of quality of life and skeletal muscle depletion following upper gastrointestinal cancer diagnosis: A longitudinal analysis.营养不良风险作为上消化道癌诊断后生活质量和骨骼肌消耗的预测指标：一项纵向分析。
J Nutr Health Aging. 2025 Jul 1;29(9):100623. doi: 10.1016/j.jnha.2025.100623.
6
The Prognostic and Early Efficacy Prediction Value of Baseline C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index in Advanced Pancreatic Cancer.基线C反应蛋白-白蛋白-淋巴细胞（CALLY）指数在晚期胰腺癌中的预后及早期疗效预测价值
Int J Gen Med. 2025 Jun 24;18:3363-3372. doi: 10.2147/IJGM.S529776. eCollection 2025.
7
Biomarkers associated with cancer-related anorexia in lung cancer: a scoping review.肺癌中与癌症相关性厌食症相关的生物标志物：一项范围综述
Support Care Cancer. 2025 Jun 19;33(7):596. doi: 10.1007/s00520-025-09670-9.
8
Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver Cancer.淋巴细胞与C反应蛋白比值：对原发性肝癌切除术后患者预后的影响
World J Surg. 2025 Aug;49(8):2195-2206. doi: 10.1002/wjs.12675. Epub 2025 Jun 17.
9
Housing Temperature Impacts the Systemic and Tissue-Specific Molecular Responses to Cancer in Mice.居住温度影响小鼠对癌症的全身和组织特异性分子反应。
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13781. doi: 10.1002/jcsm.13781.
10
Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care.实用癌症营养，从指南到临床实践：以患者为中心的数字化医疗解决方案。
ESMO Open. 2025 Apr;10(4):104529. doi: 10.1016/j.esmoop.2025.104529. Epub 2025 Apr 2.
本文引用的文献
1
Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers.阿司匹林与癌症生存率：对118项关于阿司匹林和18种癌症的观察性研究的系统评价和荟萃分析
Ecancermedicalscience. 2021 Jul 2;15:1258. doi: 10.3332/ecancer.2021.1258. eCollection 2021.
2
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis.癌症恶病质的诊断标准：国际多队列分析表明，减少食物摄入和炎症可预测体重减轻和生存。
J Cachexia Sarcopenia Muscle. 2021 Oct;12(5):1189-1202. doi: 10.1002/jcsm.12756. Epub 2021 Aug 27.
3
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines.成人癌症恶病质：ESMO 临床实践指南。
ESMO Open. 2021 Jun;6(3):100092. doi: 10.1016/j.esmoop.2021.100092.
4
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context.新型冠状病毒肺炎患者的白细胞介素-6受体阻断：临床试验背景分析
Lancet Respir Med. 2021 Jun;9(6):655-664. doi: 10.1016/S2213-2600(21)00139-9. Epub 2021 Apr 27.
5
Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.比较 MUST、ECOG-PS、mGPS 和 CT 衍生的身体成分分析在晚期肺癌患者中的预后价值。
Clin Nutr ESPEN. 2020 Dec;40:349-356. doi: 10.1016/j.clnesp.2020.08.003. Epub 2020 Sep 6.
6
New biomarkers for checkpoint inhibitor therapy.检查点抑制剂治疗的新型生物标志物。
ESMO Open. 2020 Sep;5(Suppl 1):e000597. doi: 10.1136/esmoopen-2019-000597.
7
Association of Baseline Inflammation With Effectiveness of Nutritional Support Among Patients With Disease-Related Malnutrition: A Secondary Analysis of a Randomized Clinical Trial.基线炎症与疾病相关营养不良患者营养支持有效性的关联：一项随机临床试验的二次分析。
JAMA Netw Open. 2020 Mar 2;3(3):e200663. doi: 10.1001/jamanetworkopen.2020.0663.
8
Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.ECOG-PS、mGPS 和 BMI/WL 的预后价值比较：对晚期癌症评估和治疗中具有临床重要意义的框架的影响。
Clin Nutr. 2020 Sep;39(9):2889-2895. doi: 10.1016/j.clnu.2019.12.024. Epub 2019 Dec 27.
9
The relationship between the BMI-adjusted weight loss grading system and quality of life in patients with incurable cancer.不可治愈癌症患者的 BMI 调整体重减轻分级系统与生活质量之间的关系。
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):160-168. doi: 10.1002/jcsm.12499. Epub 2019 Nov 6.
10
An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.一项探索性研究，考察晚期癌症患者的体能状态与全身炎症框架及细胞因子谱之间的关系。
Medicine (Baltimore). 2019 Sep;98(37):e17019. doi: 10.1097/MD.0000000000017019.
Zotero 插件